- $4.56bn
- $16.40bn
- $10.28bn
- 63
- 75
- 41
- 63
Annual balance sheet for Celanese, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,488 | 546 | 1,508 | 1,805 | 962 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,242 | 1,667 | 2,054 | 1,784 | 1,614 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,763 | 3,807 | 6,611 | 6,218 | 5,145 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,171 | 4,429 | 5,997 | 6,006 | 5,661 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,909 | 11,975 | 26,272 | 26,597 | 22,857 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,973 | 2,505 | 4,068 | 4,072 | 3,853 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,383 | 7,786 | 20,635 | 19,506 | 17,682 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,526 | 4,189 | 5,637 | 7,091 | 5,175 |
| Total Liabilities & Shareholders' Equity | 10,909 | 11,975 | 26,272 | 26,597 | 22,857 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |